Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6167351rdf:typepubmed:Citationlld:pubmed
pubmed-article:6167351lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:6167351lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6167351lifeskim:mentionsumls-concept:C0008497lld:lifeskim
pubmed-article:6167351lifeskim:mentionsumls-concept:C0005149lld:lifeskim
pubmed-article:6167351lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:6167351lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:6167351pubmed:issue9 Pt 1lld:pubmed
pubmed-article:6167351pubmed:dateCreated1981-10-25lld:pubmed
pubmed-article:6167351pubmed:abstractTextWhen two lines of gestational human choriocarcinoma cells (GCH-1 and GCH-2) were incubated with [35S]methionine, the labeled beta 2-microglobulin was not detected on sodium dodecyl sulfate:polyacrylamide gel electrophoresis after purification of the labeled protein with affinity chromatography, using rabbit antibody against beta 2-microglobulin as the ligand. In contrast, in the case of nongestational choriocarcinoma cells originating from male stomach cells, the incorporation of [35S]methionine into beta 2-microglobulin was observed. When polyadenylate-containing messenger RNA prepared from GCH-1 cells was incubated with [35S]methionine in a rabbit reticulocyte lysate system, the labeling of beta 2-microglobulin was not shown. On the other hand, when polyadenylate-containing messenger RNA from nongestational choriocarcinoma cells was incubated in the same cell-free system, labeled beta 2-microglobulin was detected. These results indicate that beta 2-microglobulin is not synthesized in gestational human choriocarcinoma cells and at least in the case of GCH-1, beta 2-microglobulin is not synthesized owing to the lack of effective messenger RNA for beta 2-microglobulin.lld:pubmed
pubmed-article:6167351pubmed:languageenglld:pubmed
pubmed-article:6167351pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167351pubmed:citationSubsetIMlld:pubmed
pubmed-article:6167351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167351pubmed:statusMEDLINElld:pubmed
pubmed-article:6167351pubmed:monthSeplld:pubmed
pubmed-article:6167351pubmed:issn0008-5472lld:pubmed
pubmed-article:6167351pubmed:authorpubmed-author:TanakaKKlld:pubmed
pubmed-article:6167351pubmed:authorpubmed-author:OgataKKlld:pubmed
pubmed-article:6167351pubmed:authorpubmed-author:TakahashiHHlld:pubmed
pubmed-article:6167351pubmed:authorpubmed-author:TakeuchiSSlld:pubmed
pubmed-article:6167351pubmed:authorpubmed-author:NabeshimaYYlld:pubmed
pubmed-article:6167351pubmed:issnTypePrintlld:pubmed
pubmed-article:6167351pubmed:volume41lld:pubmed
pubmed-article:6167351pubmed:ownerNLMlld:pubmed
pubmed-article:6167351pubmed:authorsCompleteYlld:pubmed
pubmed-article:6167351pubmed:pagination3639-41lld:pubmed
pubmed-article:6167351pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:meshHeadingpubmed-meshheading:6167351-...lld:pubmed
pubmed-article:6167351pubmed:year1981lld:pubmed
pubmed-article:6167351pubmed:articleTitleLack of effective messenger RNA for beta 2-microglobulin in a gestational human choriocarcinoma cell line (GCH-1).lld:pubmed
pubmed-article:6167351pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6167351pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6167351lld:pubmed